• Publications
  • Influence
Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury
Nesfatin-1 is an anorexic nucleobindin-2 (NUCB2)-derived hypothalamic peptide. It controls feeding behavior, water intake, and glucose homeostasis. If intracerebrally administered, it inducesExpand
  • 78
  • 4
COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells following binding with the cell surface ACE2 receptors, thereby leading to coronavirus disease 2019 (COVID-19).Expand
  • 36
  • 4
Phoenixin-14: detection and novel physiological implications in cardiac modulation and cardioprotection
Phoenixin-14 (PNX) is a newly identified peptide co-expressed in the hypothalamus with the anorexic and cardioactive Nesfatin-1. Like Nesfatin-1, PNX is able to cross the blood–brain barrier and thisExpand
  • 24
  • 2
The novel chromogranin A‐derived serpinin and pyroglutaminated serpinin peptides are positive cardiac β‐adrenergic‐like inotropes
Three forms of serpinin peptides, serpinin (Ala26Leu), pyroglutaminated (pGlu)‐serpinin (pGlu23Leu), and serpinin‐Arg‐Arg‐Gly (Ala29Gly), are derived from cleavage at pairs of basic residues in theExpand
  • 37
  • 2
Catestatin Increases the Expression of Anti-Apoptotic and Pro-Angiogenetic Factors in the Post-Ischemic Hypertrophied Heart of SHR
Background In the presence of comorbidities the effectiveness of many cardioprotective strategies is blunted. The goal of this study was to assess in a hypertensive rat model if the early reperfusionExpand
  • 29
  • 2
  • PDF
Receptor identification and physiological characterisation of glucagon-like peptide-2 in the rat heart.
BACKGROUND AND AIMS The anorexigenic glucagon-like peptide (GLP)-2 is produced by intestinal L cells and released in response to food intake. It affects intestinal function involvingExpand
  • 29
  • 1
Phosphodiesterase type-2 and NO-dependent S-nitrosylation mediate the cardioinhibition of the antihypertensive catestatin.
The chromogranin A (CHGA)-derived peptide catestatin (CST: hCHGA(352-372)) is a noncompetitive catecholamine-release inhibitor that exerts vasodilator, antihypertensive, and cardiosuppressiveExpand
  • 37
  • 1
  • PDF
pGlu-serpinin protects the normotensive and hypertensive heart from ischemic injury.
Serpinin peptides derive from proteolytic cleavage of Chromogranin-A at C-terminus. Serpinin and the more potent pyroglutaminated-serpinin (pGlu-Serp) are positive cardiac β-adrenergic-likeExpand
  • 15
  • 1
  • PDF
Cardiac damage in anthracyclines therapy: focus on oxidative stress and inflammation.
SIGNIFICANCE Despite their serious side effects, anthracyclines (ANTs) are the most prescribed chemotherapeutic drugs because of their strong efficacy in both solid and hematological tumors. A majorExpand
  • 3
  • 1
Progress in the emerging role of selenoproteins in cardiovascular disease: focus on endoplasmic reticulum-resident selenoproteins
Cardiovascular diseases represent one of the most important health problems of developed countries. One of the main actors involved in the onset and development of cardiovascular diseases is theExpand
  • 7
  • 1